New Two-in-One inhaler tested for lung disease
NCT ID NCT07132983
Summary
This study tested a new inhaled medicine that combines two drugs (ensifentrine and glycopyrrolate) for people with chronic obstructive pulmonary disease (COPD). The main goal was to see how the body absorbs and processes the combination compared to each drug alone, and to check if it was safe. Thirty-three adults with COPD tried single doses of the combination and the separate drugs to measure their effects on lung function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical Research of West Florida Inc - Clearwater
Clearwater, Florida, 33765-2616, United States
-
Clinical Research of West Florida Inc - Tampa
Tampa, Florida, 33606-1246, United States
-
Midwest Chest Consultants PC
Saint Charles, Missouri, 63301, United States
-
Velocity Clinical Research - Spartanburg - PPDS
Spartanburg, South Carolina, 29303-4225, United States
Conditions
Explore the condition pages connected to this study.